Kim Kataguiri: Mr. President, we instruct 'yes' and, in the same sense as Deputy Gilson, we also wanted to record the Missão party's vote on both urgency motions that were previously voted. Thank you.
Mr. President, article 74 of the Procurement Law already addresses the case of inexigibility when there is only a single supplier, when there is only a single agent capable of supplying that product, supplying that service, a case which today is already the reality at Hemobrás.
Kim Kataguiri: So, in my assessment, extending it — and I believe there is even a problem of legislative technique, there will be disagreement when discussing the jurisprudence of this new wording at the STJ (Superior Court of Justice) — I find it problematic to include a new provision for public institutions exclusively for the health system, exclusively for a new product, when today it is already not required when there is a single company.
Kim Kataguiri: We may be preventing the contracting, by means of a competitive tender, of a better product, better for the patient, cheaper for the Unified Health System and that gives more quality of life to the end user. So, the guidance is 'no', Mr. President.